2.58

16.23% -0.50

After Hours: 2.32 -0.26 -10.08%

Dermata Therapeutics Inc (DRMA)

Overview News Price History Financials Discussions Forecast Stock Split

Dermata Therapeutics Inc stock is traded at $2.58, with a volume of 1.03M. It is down -16.23% in the last 24 hours and up +38.71% over the past month. Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.

Previous Close:

$3.08

Open:

$2.82

24h Volume:

1.03M

Relative Volume:

0.80

Market Cap:

$7.32M

Revenue:

Net Income/Loss:

$-11.27M

P/E Ratio:

-0.1205

EPS:

-21.4132

Net Cash Flow:

$-9.40M

1W Performance:

+18.89%

1M Performance:

+38.71%

6M Performance:

-63.10%

1Y Performance:

-78.14%

1-Day Range:

$2.49

$2.9982

1-Week Range:

$2.01

$4.66

52-Week Range:

$1.58

$23.70

Dermata Therapeutics Inc Stock (DRMA) Company Profile

Name

Dermata Therapeutics Inc

Sector

Healthcare (1113)

Industry

Biotechnology (624)

Phone

(858)-223-0882

Address

3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO

Employee

Twitter

Next Earnings Date

2024-08-15

Latest SEC Filings

DRMA's Discussions on Twitter

Compare DRMA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DRMA Dermata Therapeutics Inc	2.58	8.73M	0	-11.27M	-9.40M	-21.41
VRTX Vertex Pharmaceuticals Inc	474.17	120.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	771.25	80.15B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	864.42	51.56B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	354.75	47.74B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	336.16	37.38B	4.98B	69.59M	525.67M	0.5197

Dermata Therapeutics Inc Stock (DRMA) Latest News

12:57 PM

Meme Stocks: Will Dermata Therapeutics Inc Equity Warrant outperform the market in YEARPortfolio Gains Report & AI Powered Market Entry Strategies - baoquankhu1.vn

12:57 PM

10:39 AM

Dermata Therapeutics increases at-the-market offering by $705,000 By Investing.com - Investing.com South Africa

10:39 AM

Dermata Therapeutics increases at-the-market offering by $705,000 - Investing.com South Africa

10:39 AM

09:33 AM

Gap Down: Why is AHLPRF stock going downMarket Activity Report & Accurate Intraday Trade Tips - baoquankhu1.vn

Jan 26, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Jan 26, 2026

Whats next for M3 Brigade Acquisition V Corp stockJuly 2025 Spike Watch & Precise Buy Zone Identification - baoquankhu1.vn

Jan 26, 2026

Jan 21, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Jan 21, 2026

Aug Momentum: Does RRGB meet Warren Buffetts criteriaMarket Trend Summary & Precise Swing Trade Alerts - baoquankhu1.vn

Jan 21, 2026

Dermata receives Australian patent for Spongilla acne treatment By Investing.com - Investing.com Nigeria

Jan 21, 2026

Jan 20, 2026

Dermata receives Australian patent for Spongilla acne treatment - Investing.com

Jan 20, 2026

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office - ACCESS Newswire

Jan 20, 2026

3.3M Australians with acne: Dermata's new treatment patent - Stock Titan

Jan 20, 2026

Jan 18, 2026

Will Dermata Therapeutics Inc. stock outperform growth indexesJuly 2025 Reactions & Stock Market Timing Techniques - bollywoodhelpline.com

Jan 18, 2026

Jan 15, 2026

Fundamentals Check: Will Dermata Therapeutics Inc benefit from seasonalityTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn

Jan 15, 2026

Jan 14, 2026

Can Grace Therapeutics Inc. weather a recessionRate Cut & Safe Capital Growth Trade Ideas - bollywoodhelpline.com

Jan 14, 2026

Jan 10, 2026

How buybacks impact Dermata Therapeutics Inc. stock value2025 Trade Ideas & Verified Stock Trade Ideas - ulpravda.ru

Jan 10, 2026

Can Dermata Therapeutics Inc. Equity Warrant stock deliver consistent earnings growthQuarterly Profit Report & AI Based Trade Execution Alerts - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com

Jan 09, 2026

Will Dermata Therapeutics Inc. stock attract more institutional investorsFit and Size Notes & support options for steady strides - Улправда

Jan 09, 2026

Jan 08, 2026